United Therapeutics (UTHR) Tops Q2 EPS by 82c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $541.83 -0.57%
EPS Growth %: +11.9%
Financial Fact:
Selling, general and administrative: 100.1M
Today's EPS Names:
DTGI, CRMT, STZ, More
EPS Growth %: +11.9%
Financial Fact:
Selling, general and administrative: 100.1M
Today's EPS Names:
DTGI, CRMT, STZ, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $3.68, $0.82 better than the analyst estimate of $2.86. Revenue for the quarter came in at $362 million versus the consensus estimate of $339.97 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Cronos Group replaces broker for Canadian share repurchase program
- Trump's annual disclosures show $236 million in crypto proceeds, gifts worth $370,000
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
